Stock Report

Download full stock data and analysis for free Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Regencell Bioscience Holdings (RGC) Key Ratios

Stock Card factsheet share-fund-plan-icon

$7.03

up-down-arrow $1.53 (27.81%)

As on 04-Sep-2026 13:35EDT

Market cap

info icon

$2,621 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

2234.4

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -- -- 17.85 15.18 -219.26
Net Profit -- -- 16.68 14.91 -219.26
EPS -- -- 16.69 14.91 -206.81
Book Value -- -- -40.86 -34.21 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsJun-25Jun-24Jun-23
EBIT-Margin info ----------
Net Margin info ----------
Return on equity info -45.89-42.15-54.81-42.49-40.36
Return on Capital info -44.12-564.66-52.29-41.37-38.71
Return on Assets info -43.23-105.18-50.50-40.85-38.32
Debt to Equity (x) info ----0.110.010.04

Profitability

View Detailed Peer Comparison

ROCE

-52.29

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
-52.29
-41.37
-38.71
-84.73
-2,606.18
Peer Median
--
--
--
--
--
ROE

-54.81

--

Profit after tax / Average Net worth * 100

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
-54.81
-42.49
-40.36
-113.60
40.51
Peer Median
--
--
--
--
--
ROA

-50.50

--

Profit after tax / Average Total assets * 100

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
-50.50
-40.85
-38.32
-80.86
-315.34
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
--
--
--
--
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
--
--
--
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
--
--
--
--
Peer Median
--
--
--
--
--
EBIT Growth

17.85

--

Year on year growth in operating profit (EBIT)

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
17.85
28.03
20.18
-449.79
-70.04
Peer Median
--
--
--
--
--
Net Profit Growth

16.68

--

Year on year growth in profit after tax

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
16.68
26.73
20.90
-451.16
-65.78
Peer Median
--
--
--
--
--
EPS Growth

0.17

--

Year on year growth in earnings per share

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
0.17
0.27
0.21
-3.24
-0.66
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.11

--

Total debt / Net worth

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
0.11
0.01
0.04
0.05
-0.92
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.06

--

(Short term borrowings / Net worth)

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
0.06
0.01
0.04
0.02
-0.92
Peer Median
--
--
--
--
--
Current Ratio

7.39

--

Current Assets / Current Liabilities and Provisions

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
7.39
41.92
19.15
28.46
0.02
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
42.71
19.24
28.51
0.02
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
--
--
-327.14
--
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
--
--
--
--
Peer Median
--
--
--
--
--
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
--
--
--
--
Peer Median
--
--
--
--
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
--
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

-142.08

--

Average Inventory / Sales * 365

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
-142.08
-51.27
-19.97
-10.59
-102.66
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
--
--
--
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
--
--
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-2,350.85

--

Current share price divided by earning per share in the last twelve months

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
-2,350.85
-386.21
-1,940.52
-2,305.32
--
Peer Median
--
--
--
--
--
Price / Book Value

1,733.64

--

Current share price divided by book value per share in the latest financial year

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
1,733.64
202.15
947.02
1,002.71
--
Peer Median
--
--
--
--
--
EV/EBITDA

-2,638.78

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Jun-25
Jun-24
Jun-23
Jun-22
Jun-21
Regencell Bioscience Holdings (RGC)
-2,638.78
-457.08
-2,150.52
-2,445.75
--
Peer Median
--
--
--
--
--
loading...
loading...